Minimum Intensity Anticoagulation Therapy as Primary Prevention Strategy

Coronary heart disease is a major public health problem, and even a small reduction in the number of adverse events will go a long way toward reducing morbidity and mortality, thereby cutting down the cost of health care significantly. Minimum intensity anticoagulation therapy as a primary preventive measure is a promising area that has been examined by MacCallum et al¹ and has huge implications in terms of resource allocation.